| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2006 | CN1240390C Biologic converted ginseng composition and preparing process thereof |
| 02/08/2006 | CN1240389C Sulfony lated acetylglucosamine medicinal composition and its use |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/08/2006 | CN1240387C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 02/08/2006 | CN1240386C Matrix metal proteinase and tumor necrosis inhibitor |
| 02/08/2006 | CN1240385C Method for preparing nimodipine carrying float sustained release mini capsule |
| 02/08/2006 | CN1240384C Transdermal administration of huperzine |
| 02/08/2006 | CN1240383C Sophoridine soft capsule for curing malignant tumor, its preparation method and purposes |
| 02/08/2006 | CN1240382C Medicine combinations using pyridoindolone derivatives and anticancer agent as base |
| 02/08/2006 | CN1240381C Use of 5-hydroxymethyl furfural in preparation of medicine and healthcare product for prevention and treatment of degenerative disease of nervous system and cognize hurt |
| 02/08/2006 | CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole |
| 02/08/2006 | CN1240379C Lipid peroxide-lowering compositions |
| 02/08/2006 | CN1240378C Externally applied preparation for removing dampness and relieving osteodynia and preparation method thereof |
| 02/08/2006 | CN1240377C Stable pharmaceutical composition of pravastatin |
| 02/08/2006 | CN1240375C Preparation of low dosage medicinal composition with uniform distribution and effect |
| 02/08/2006 | CN1240374C Rapidly disintegrating methylcellulose tablets |
| 02/08/2006 | CN1240322C Composition and use |
| 02/07/2006 | USRE38970 Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors |
| 02/07/2006 | USRE38968 raloxifene hydrochloride |
| 02/07/2006 | US6996473 Method for screening and producing compound libraries |
| 02/07/2006 | US6995285 ABCA-1 elevating compounds |
| 02/07/2006 | US6995284 Synthesis of selective androgen receptor modulators |
| 02/07/2006 | US6995283 Benzophenones as inhibitors of reverse transcriptase |
| 02/07/2006 | US6995278 Antiangiogenic agents |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995261 Treatment of meningitis, septic shock, infections, reperfusion injuries, hepatitis, pancreatitis; bone, autoimmune, viral, and respiratory system disorders; antiinflammatory, antiarthritic, and antitumor agents |
| 02/07/2006 | US6995260 Carboranylporphyrins and uses thereof |
| 02/07/2006 | US6995209 Having a continuous aqueous phase comprising a thermally reversible viscosifying polymer, especially a polymer having a polyoxyalkylene block having a hydrophobic region and a hydrophilic region and an optionally substituted acrylic acid |
| 02/07/2006 | US6995190 Method and treatment with ketoprofen solution |
| 02/07/2006 | US6995189 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 02/07/2006 | US6995188 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 02/07/2006 | US6995187 Peripheral cannabinoid receptor (CB2) selective ligands |
| 02/07/2006 | US6995186 For therapy of allergic or inflammatory disorders of the eye and nose |
| 02/07/2006 | US6995185 Δ1-pyrrolines used as pesticides |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995180 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders |
| 02/07/2006 | US6995179 N-type calcium channel blockers, antiischemic agents |
| 02/07/2006 | US6995178 Insecticidal anthranilamides |
| 02/07/2006 | US6995176 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/07/2006 | US6995175 Anticancer agents |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995173 Using quinolinone drug |
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995171 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents |
| 02/07/2006 | US6995170 formed by reacting 7-halogeno-8-cyano-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid with (1S,6S)-2,8-diazabicyclo[4.3.0]nonane in presence of base/diluent; for use as antibacterial agent |
| 02/07/2006 | US6995169 Synergistic mixture |
| 02/07/2006 | US6995168 such as 5-[8-(3-dimethylcarbamoyl-3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-pentanoic acid; side effect reduction; for stimulating opioid receptors |
| 02/07/2006 | US6995167 Arylkylamine spirofuropyridines useful in therapy |
| 02/07/2006 | US6995166 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 02/07/2006 | US6995165 Methods, compositions, and kits for organ protection during systemic anticancer therapy |
| 02/07/2006 | US6995164 Methods of treating tumors |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995160 Sodium channel blockers |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995158 Administering folic acid or a folate and tetrahydrobiopterin (BH4) for reducing superoxide (O2) production and enhancing nitric oxide (NO) synthesis |
| 02/07/2006 | US6995157 Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | US6995155 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease |
| 02/07/2006 | US6995154 Catalyst for joining, breaking of Dna; antitumor, anticancer agents |
| 02/07/2006 | US6995153 tachykinin receptor antagonist, in particular, an NK1 receptor antagonist; prophylactic or therapeutic agent against tachykinin receptor-related pathological conditions, including increased urinary frequency, incontinence, vomiting, inflammation |
| 02/07/2006 | US6995152 Diagnosis and treatment of human kidney diseases |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995149 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen |
| 02/07/2006 | US6995148 Hypotensive agents, vasodilation, antiischemic agents, cardiovascular disorders |
| 02/07/2006 | US6995147 Method of delaying the onset of diabetes |
| 02/07/2006 | US6995146 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 02/07/2006 | US6995145 By treating a cancer with paclitaxel and a telomerase inhibitory agent, such as AZT, telomere damage induced resistance to paclitaxel is avoided |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995143 Therapy against antibiotic resistance infections |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/07/2006 | US6995137 Water-soluble natural film and its preparing method |
| 02/07/2006 | US6995134 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 02/07/2006 | US6994981 Modulators of paraptosis and related methods |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994873 Modified release granules |
| 02/07/2006 | US6994869 amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having adverse affect |
| 02/07/2006 | US6994868 Compositions useful as inhibitors of ERK |
| 02/07/2006 | US6994864 Cosmetics for dermatological treatment and prevention of skin aging due to actinic radiation |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994862 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | US6994846 Composition for cosmetic or dermatological use containing a triblock polymer |
| 02/07/2006 | US6994843 Delivery of stimulants through an inhalation route |
| 02/07/2006 | US6994842 Aerogel powder therapeutic agents |
| 02/07/2006 | US6994283 Method for pulverizing to fine powder |
| 02/07/2006 | CA2450111C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 02/07/2006 | CA2375040C Orally active a1 adenosine receptor agonists |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2316082C Substituted 2-benzylamino-2-phenyl-acetamide compounds |